Therefore, we hypothesized that the use of G-CSF in the prevention of chemotherapy-induced neutropenia in ALL patients may support regeneration of damaged tissues by mobilization of stem and progenitor cells. The gene discussed is CSF3; the disease is acute lymphoblastic leukemia.